IST:GENIL's 5-Year Yield-on-Cost % is ranked worse than 93.41% of 516
companies
in the Drug Manufacturers industry
Industry Median: 2.205
vs IST:GENIL: 0.20
Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Gen Ilac Veglik Urunlerinayi ve Ticaret AS 5-Year Yield-on-Cost % Related Terms
IST:GENIL vs ZTS, UTHR, VTRS: 5-Year Yield-on-Cost % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gen Ilac Veglik Urunlerinayi ve Ticaret AS 5-Year Yield-on-Cost % vs Drug Manufacturers Industry
Gen Ilac Veglik Urunlerinayi ve Ticaret AS 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) has a 5-Year Yield-on-Cost % of 0.20 as of Jul. 12, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Gen Ilac Veglik Urunlerinayi ve Ticaret AS and its competitors. This is 70% below median its historical median of 0.66. Over the past decade, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's 5-Year Yield-on-Cost % has ranged from 0.20 to 2.72. According to the industry distribution chart, Gen Ilac Veglik Urunlerinayi ve Ticaret AS ranks #482 out of 516 companies in the Drug Manufacturers industry, placing it in the top 93.4%.
Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS's 5-Year Yield-on-Cost % too high?
Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current 5-Year Yield-on-Cost % of 0.20 is 70% below median its 10-year median of 0.66. Over the past 10 years, this metric has ranged from a low of 0.20 to a high of 2.72. The Drug Manufacturers industry median 5-Year Yield-on-Cost % is 2.21. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's value of 0.20 is 90.9% below this industry median. Based on the distribution chart, Gen Ilac Veglik Urunlerinayi ve Ticaret AS ranks #482 out of 516 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Gen Ilac Veglik Urunlerinayi ve Ticaret AS has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Gen Ilac Veglik Urunlerinayi ve Ticaret AS's 5-Year Yield-on-Cost % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Gen Ilac Veglik Urunlerinayi ve Ticaret AS ranks #482 out of 516 companies for 5-Year Yield-on-Cost %. This places Gen Ilac Veglik Urunlerinayi ve Ticaret AS in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.21. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's value of 0.20 is 90.9% below this benchmark. Historically, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's own 5-Year Yield-on-Cost % has ranged from 0.20 to 2.72 over the past decade. While the company's 10-year median is 0.66 vs. the industry median of 2.21, Gen Ilac Veglik Urunlerinayi ve Ticaret AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.21, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current 5-Year Yield-on-Cost % of 0.20 is 90.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Gen Ilac Veglik Urunlerinayi ve Ticaret AS and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current 5-Year Yield-on-Cost % is 0.20, which is 70% below median its own 10-year median of 0.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS stock overvalued right now?
Based on GuruFocus' analysis, Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) is currently considered Modestly Overvalued. The stock's GF Value™ is ₺8.17, compared to a current price of ₺9.10 — trading 11.4% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.20, which is 70% below median its 10-year median of 0.66 and 90.9% below the Drug Manufacturers industry median of 2.21. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL), the current 5-Year Yield-on-Cost % is 0.20 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Overvalued in 2026?
Based on GuruFocus' analysis, Gen Ilac Veglik Urunlerinayi ve Ticaret AS stock appears to be overvalued.
The current stock price of ₺9.10 is trading 11.4% above its estimated GF Value™ of ₺8.17.
GuruFocus considers Gen Ilac Veglik Urunlerinayi ve Ticaret AS to be Modestly Overvalued.
Key valuation signals for IST:GENIL:
5-Year Yield-on-Cost %: 0.20 (70% below median its 10-year median of 0.66)
GF Value™: ₺8.17 vs. price of ₺9.10 (11.4% above fair value)
Industry Position: 90.9% below the Drug Manufacturers median (#482 of 516)
No single metric tells the full story. See the IST:GENIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gen Ilac Veglik Urunlerinayi ve Ticaret AS Business Description
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS is a specialty pharmaceuticals company in Turkey. Its locally manufactured products include Cajex, Contra-K, Epamor, Genkort, Ilopera, among others, while imported products include AvonexPEN, Plegridy, Tecfidera, Regen-D among others.
86GF Score
Get the complete analysis for IST:GENIL
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:GENIL has been successfully added to your 